Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Study

• Register: ClinicalTrials.gov
• Last refreshed on: 11 April 2016
• Main ID: NCT02675010
• Date of registration: 02/02/2016
• Prospective Registration: No
• Primary sponsor: Mansoura University
• Public title: Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Study
• Scientific title: Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Multicenter Study
• Date of first enrolment: June 2014
• Target sample size: 400
• Recruitment status: Active, not recruiting
• URL: https://clinicaltrials.gov/show/NCT02675010
• Study type: Interventional
• Study design: Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
• Phase: N/A

Countries of recruitment

Egypt

Contacts

• Name: MOHAMED ABDELLATIF, ASS PROF
• Affiliation: MANSOURA FACULTY OF MEDICINE

Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients included in this study are those with peptic ulcer disease, previous upper
gastrointestinal surgery, a known or a suspected past history of H.pylori eradication
therapy, a personal or first-degree family history of gastric cancer

Exclusion Criteria:

- those having received antibiotic or proton pump inhibitor treatment one month
beforehand



Age minimum: N/A
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

CORPUS BIOPSIES

Gastric Antrum

Helicobacter Pylori

Intervention(s)

Other: ENDOSCOPIC GASTRIC BIOPSIES FROM ANTRUM AND BODY

Primary Outcome(s)

H PYLORI POSITIVITY [Time Frame: 2 YEARS]

Secondary ID(s)

H1

Source(s) of Monetary Support

Please refer to primary and secondary sponsors